0001415889-23-013292.txt : 20230914
0001415889-23-013292.hdr.sgml : 20230914
20230914173130
ACCESSION NUMBER: 0001415889-23-013292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230913
FILED AS OF DATE: 20230914
DATE AS OF CHANGE: 20230914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peterson Kristine
CENTRAL INDEX KEY: 0001508596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 231256025
MAIL ADDRESS:
STREET 1: AMARIN CORPORATION
STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE
CITY: MYSTIC
STATE: CT
ZIP: 06355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ImmunoGen, Inc.
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOGEN INC
DATE OF NAME CHANGE: 19920703
4
1
form4-09142023_090924.xml
X0508
4
2023-09-13
0000855654
ImmunoGen, Inc.
IMGN
0001508596
Peterson Kristine
C/O IMMUNOGEN, INC.
830 WINTER STREET
WALTHAM
MA
02451
true
false
false
false
0
Common Stock
2023-09-13
4
M
0
10000
14.70
A
10000
D
Common Stock
2023-09-13
4
M
0
10000
16.08
D
0
D
Stock Option (Right to Buy)
14.70
2023-09-13
4
M
0
10000
0
D
2023-11-12
Common Stock
10000
0
D
Effected pursuant to a trading plan adopted on June 11, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
This option was granted on 11/12/2013 and is fully vested as of the transaction date.
/s/ Renee Lentini, Attorney-in-Fact
2023-09-14